Hydrix (HYD) Stock Overview

Hydrix Limited provides product design, engineering, and regulatory consulting services in Australia, Singapore, Europe, North America, and internationally. The company operates through three segments: Hydrix Services, Hydrix Medical, and Hydrix. Its products portfolio comprises The GUARDIAN, a cardiac monitoring device that alerts and warns patients to seek medical attention for acute coronary syndrome (ACS), including silent heart attacks; LUDO, a customizable plug-and-play platform that offers critical tools to start MCS pump development; EchoSolv, a cloud-based decision support platform, which provides physicians with tools to identify patients at-risk of structural heart disease; and Implicity, an AI-driven RM solution that delivers cardiovascular monitoring technology and data management tools, which supports health professionals in the diagnosis, rehabilitation, and surveillance of cardiovascular patients. The company also offers a range of services, including product development, and regulatory and clinical consulting. It serves industrial, utilities, defense, aerospace, and mining industries. The company was formerly known as Panorama Synergy Limited and changed its name to Hydrix Limited in November 2018. Hydrix Limited was incorporated in 1993 and is headquartered in Mulgrave, Australia